Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...

3SBio will grant Pfizer exclusive global rights, not including China, to develop, manufacture and commercialize SSGJ-707, a ...

Squeezed by insurers and middlemen, independent pharmacists such as Mr Jolley find themselves on the front lines of a tariff storm. Nearly everyone down the line — drugmakers, pharmacies, wholesalers, ...

An Enquirer analysis found that doctors, nurses and other practitioners received $136 million from pharma and biotech ...

McKesson Corporation announced its intention to separate its Medical-Surgical Solutions segment into an independent company.

President Donald Trump’s latest bid to slash prescription drug prices has once again stirred heated debate about the high costs paid by U.S. patients.

President Donald Trump’s plan to change the pricing model for some medications is facing fierce criticism from the ...

President Donald Trump says he'll sign an executive order on Monday that, if implemented, could bring down the costs of some ...

Billionaire pharmaceuticals company owner Dennis Bastas is firming as the likely buyer behind Melbourne's priciest ever home ...

The UK exports a relatively small amount of steel and aluminium to the US, about £700m in total. However, the tariffs also cover products made with steel and aluminium, including things such as gym ...

The ink on Britain’s landmark post-Brexit trade deal with India had hardly dried before the news broke that an agreement with ...

The pharmaceutical industry estimates President Donald Trump’s new drug pricing proposal could cost drug companies as much as $1 trillion over a decade, its largest trade group is telling members of ...